WiseGuyReports

Oligonucleotide Therapeutics 2018 Global Market Expected to Grow at CAGR 9.52% and Forecast to 2022

 

New York, NY -- (SBWIRE) -- 07/16/2018 -- Global Oligonucleotide Therapeutics Market

WiseGuyRerports.com Presents "Global Oligonucleotide Therapeutics Market 2018-2022" New Document to its Studies Database. The Report Contain 103 Pages With Detailed Analysis.

Description

Oligonucleotides are short nucleotides sequences of DNA or RNA molecules called oligomers. Oligonucleotide therapeutics target and inhibit the expression of certain diseases-causing genes, thus forming a new class of therapeutics to treat chronic diseases.

The analysts forecast the Global Oligonucleotide Therapeutics Market to grow at a CAGR of 9.52% during the period 2018-2022.

Covered in this report 
The report covers the present scenario and the growth prospects of the oligonucleotide therapeutics market. To calculate the market size, the report considers the revenue generated from the sales of oligonucleotide therapeutics.

Get sample Report @ https://www.wiseguyreports.com/sample-request/3249258-global-oligonucleotide-therapeutics-market-2018-2022

 

The market is divided into the following segments based on geography: 
- Americas 
- APAC 
- EMEA

The oligonucleotide therapeutics market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
- Arrowhead Pharmaceuticals 
- GlaxoSmithKline 
- Ionis Pharmaceuticals 
- miRagen Therapeutics 
- Sarepta Therapeutics

Market driver 
- Increased availability of approved drugs 
- For a full, detailed list, view our report

 Market challenge 
- Inherent challenges with oligonucleotide therapies 
- For a full, detailed list, view our report

Market trend 
- Increasing M&A 
- For a full, detailed list, view our report

Key questions answered in this report 
- What will the market size be in 2022 and what will the growth rate be? 
- What are the key market trends? 
- What is driving this market? 
- What are the challenges to market growth? 
- Who are the key vendors in this market space? 
- What are the market opportunities and threats faced by the key vendors? 
- What are the strengths and weaknesses of the key vendors?

Complete Report Details @ https://www.wiseguyreports.com/reports/3249258-global-oligonucleotide-therapeutics-market-2018-2022

 

Table of Contents -Major Key Points

PART 01: EXECUTIVE SUMMARY 

PART 02: SCOPE OF THE REPORT 

PART 03: RESEARCH METHODOLOGY 

PART 04: MARKET LANDSCAPE 
- Market ecosystem 
- Market characteristics 
- Market segmentation analysis 

PART 05: MARKET SIZING 
- Market definition 
- Market sizing 2017 
- Market size and forecast 2017-2022 

PART 06: FIVE FORCES ANALYSIS 
- Bargaining power of buyers 
- Bargaining power of suppliers 
- Threat of new entrants 
- Threat of substitutes 
- Threat of rivalry 
- Market condition 

PART 07: MARKET SEGMENTATION BY APPLICATION 
- Segmentation by application 
- Comparison by application 
- Neurological disorders – Market size and forecast 2017-2022 
- Cancer – Market size and forecast 2017-2022 
- Others – Market size and forecast 2017-2022 
- Market opportunity by application 

PART 08: MARKET SEGMENTATION BY TECHNOLOGY 
- Segmentation by technology 
- Comparison by technology 
- Antisense/RNAi oligonucleotides – Market size and forecast 2017-2022 
- Others – Market size and forecast 2017-2022 
- Market opportunity by technology 

PART 09: CUSTOMER LANDSCAPE 

PART 10: REGIONAL LANDSCAPE 
- Geographical segmentation 
- Regional comparison 
- Americas – Market size and forecast 2017-2022 
- EMEA – Market size and forecast 2017-2022 
- APAC – Market size and forecast 2017-2022 
- Key leading countries 
- Market opportunity 

PART 11: DECISION FRAMEWORK 

PART 12: DRIVERS AND CHALLENGES 
- Market drivers 
- Market challenges 

PART 13: MARKET TRENDS 
- Increasing M&A 
- Advances in DNA sequencing increases use of microfluidic techniques 
- Increasing drugs in pipeline 

PART 14: VENDOR LANDSCAPE 
- Overview 
- Landscape disruption 

PART 15: VENDOR ANALYSIS 
- Vendors covered 
- Vendor classification 
- Market positioning of vendors 
- Arrowhead Pharmaceuticals 
- GlaxoSmithKline 
- Ionis Pharmaceuticals 
- miRagen Therapeutics 
- Sarepta Therapeutics 

 ……..CONTINUED